Pfizer gaining antisense oligonucleotide in Excaliard buy
23 November 2011
Donna Young
Please Login to read the full article.
23 November 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amylin and Bristol-Myers Squibb deny reports that Amylin rejected $3.5 billion offer
- "Welcome home": Stromedix buy brings fibrosis drug back to Biogen
- RXi to spin off RNAi and focus on targeted cancer therapies
- Amylin seeking first US approval for lipodystrophy with metreleptin
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
